Cantargia AB
STO:CANTA

Watchlist Manager
Cantargia AB Logo
Cantargia AB
STO:CANTA
Watchlist
Price: 1.812 SEK -2.42% Market Closed
Market Cap: 332.8m SEK
Have any thoughts about
Cantargia AB?
Write Note

Cantargia AB
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cantargia AB
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Cantargia AB
STO:CANTA
Total Liabilities & Equity
kr79m
CAGR 3-Years
-52%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Total Liabilities & Equity
kr2.3B
CAGR 3-Years
7%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Total Liabilities & Equity
kr778.7m
CAGR 3-Years
31%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Total Liabilities & Equity
kr16.9B
CAGR 3-Years
40%
CAGR 5-Years
52%
CAGR 10-Years
41%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Total Liabilities & Equity
kr72.2B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
27%
BioArctic AB
STO:BIOA B
Total Liabilities & Equity
kr1.2B
CAGR 3-Years
4%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
No Stocks Found

Cantargia AB
Glance View

Market Cap
332.8m SEK
Industry
Biotechnology

Cantargia AB is a holding company, which engages in the development of antibody-based cancer treatment. The company is headquartered in Lund, Skane. The company went IPO on 2015-03-17. The firm is engaged in the development of a therapy for the treatment of cancer by targeting a cell-surface receptor on malignant stem cells, through the development of antibody therapeutics for eradication of malignant stem cells. Cantargia AB uses the Interleukin-1 receptor accessory protein (IL1RAP), as the target for development of a novel antibody-based therapy for leukemia.

CANTA Intrinsic Value
1.024 SEK
Overvaluation 44%
Intrinsic Value
Price

See Also

What is Cantargia AB's Total Liabilities & Equity?
Total Liabilities & Equity
79m SEK

Based on the financial report for Sep 30, 2024, Cantargia AB's Total Liabilities & Equity amounts to 79m SEK.

What is Cantargia AB's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
-18%

Over the last year, the Total Liabilities & Equity growth was -67%. The average annual Total Liabilities & Equity growth rates for Cantargia AB have been -52% over the past three years , -18% over the past five years .

Back to Top